Aim: Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen with very low/no expression in normal tissues. PRAME is an important target for tumor immunotherapy. Prognostic and in some tumors predictive importance of this expression have been shown in some...
Open access
Research Article10.9734/IBRR/2014/8832
Aims: The management of relapsed/refractory Hodgkin lymphoma is challenging and new choices are needed. Brentuximab vedotin and bendamustine are two effective drugs in these cases. The aim of this study is to present the response to bendamustine after brentuximab failure. Study D...
Open access
Research Article10.9734/IBRR/2014/8834
Introduction: Renal cell carcinoma (RCC) is the third most common urological cancer. Skeletal metastases from renal cell carcinoma are common, but metastatic tumors involving the hand and foot are rare. This is known as acrometastases and is usually a late manifestation ofdissemi...
Open access
Research Article10.9734/IJMPCR/2015/17236